SS-31 (Elamipretide) Dosage Guide
75/100 confidenceComplete guide to SS-31 (Elamipretide) dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
40 mg
Route
subq
Frequency
1x daily
Cycle Length
4-12 weeks
Reconstitution
Vial Size
50 mg
BAC Water
2 ml
Concentration
25,000 mcg/ml
Detailed Dosage Information
Clinical trials have used IV infusions of 0.25mg/kg for acute conditions. Subcutaneous dosing protocols for research use typically range from 1-5mg daily.
Administration Method
Can be administered IV or subcutaneously. Most clinical research has used IV administration for cardiac conditions.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 25,000 mcg/ml
Volume to inject: 1.60 ml
Syringe units (U-100): 160.0 units
Pre-filled with SS-31 (Elamipretide) defaults. Adjust values as needed.
Research Backing
Phase 2/3 trials (e.g., MMPOWER, ARISE) and ongoing studies for primary mitochondrial myopathy; strong mechanistic data.
Side Effects to Monitor
Generally well-tolerated. Clinical trials reported injection site reactions and occasional headache.
Safety Considerations & Risks
Failed to meet primary endpoints in some heart failure trials. Long-term effects still being studied. Expensive for research use.